000504SZSE

*ST Bio Co., Ltd.

*ST生物

000504

Shenzhen Stock Exchange

Follow
43 announcements tracked· Last: May 21, 2026

Key Financials

As of 2026-05-16T00:00:00.000+00:00
Revenue¥119.3M
Net Profit¥11.1M
ROE4.01%
Debt Ratio63.69%
Monetary Funds¥183.4M
Receivables¥164.3M
Goodwill¥6.2M
Total Shares330.0M

Announcements

41 total

Nanhua Bio Progress Announcement on Application to Withdraw Delisting Risk Warning

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Nanhua Biological 2025 Annual Board Audit Committee Performance Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Nanhua Biological Announcement on 2025 Annual Uncovered Losses Exceeding One-Third of Paid-in Capital

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Nanhua Biological Announcement on Adjusting Members of the Board's Special Committees

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Nanhua Biological 2025 Annual Board Work Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Nanhua Biological Three-Year Shareholder Return Plan (2026-2028)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Nanhua Biological 2025 Annual Goodwill Impairment Test Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Nanhua Biological 2025 Annual Financial Settlement Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

2025 Audit Report of Nanhua Bio

Share PledgeShareholding Change DisclosureListed Company Announcements

Announcement on the 2026 Director Compensation Plan of Nanhua Bio

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the 2026 Senior Management Compensation Plan of Nanhua Bio

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Independent Director's 2025 Annual Work Report of Nanhua Bio (She Liwen)

Convertible BondsShareholding Change DisclosureListed Company Announcements

Independent Director's 2025 Annual Work Report of Nanhua Bio (Zhu Limei)

Convertible BondsShareholding Change DisclosureListed Company Announcements

Independent Director's 2025 Annual Work Report of Nanhua Bio (Lin Feng)

Convertible BondsShareholding Change DisclosureListed Company Announcements

Independent Director's 2025 Annual Work Report of Nanhua Bio (Zhao Yaqing - Resigned)

Convertible BondsShareholding Change DisclosureListed Company Announcements

Nanhua Bio 2025 Internal Control Audit Report

Share PledgeShareholding Change DisclosureListed Company Announcements

Nanhua Bio 2025 Annual Internal Control Self-Evaluation Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Nanhua Bio Director and Senior Management Compensation Management System

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on Changes in Accounting Policies by Nanhua Bio

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Provision for Credit Impairment, Asset Impairment, and Write-off of Certain Assets by Nanhua Bio for 2025

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

West Securities Co., Ltd. on the Summary Report of Continuous Supervision and Sponsorship for Nanhua Bio Pharmaceutical Co., Ltd. Issuing Stocks to Specific Objects

Shareholder Share IncreaseShareholding Change DisclosureListed Company Announcements

Special Report on the Annual Storage, Management, and Actual Use of Raised Funds for Nanhua Bio in 2025

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

West Securities Co., Ltd. on the Special Verification Opinion of the 2025 Annual Storage, Management, and Actual Use of Raised Funds of Nanhua Bio Pharmaceutical Co., Ltd.

Share PledgeShareholding Change DisclosureListed Company Announcements

West Securities Co., Ltd. on the Verification Opinion of the 2025 Annual Internal Control Self-Evaluation Report of Nanhua Bio Pharmaceutical Co., Ltd.

Share Repurchase CompletionShareholder Share IncreaseShare Pledge

West Securities Co., Ltd. on the 2025 Annual Sponsorship Work Report of Nanhua Bio Pharmaceutical Co., Ltd.

Shareholder Share IncreaseShare PledgeShareholding Change Disclosure

Notice of the 2025 Annual Shareholders' Meeting of Nanhua Bio

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement of the Resolutions of the 9th Meeting of the 12th Board of Directors of Nanhua Bio

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Proposed Non-Distribution of Profits for 2025 by Nanhua Bio

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Verification Report on the Annual Storage, Management, and Actual Use of Raised Funds for Nanhua Bio in 2025

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

Special Verification Report on Non-Recurring Gains and Losses of Nanhua Bio

Share PledgeShareholding Change DisclosureListed Company Announcements

Special Audit Report on Revenue Deduction by Accounting Firm

Share PledgeShareholding Change DisclosureListed Company Announcements

Evaluation Report on the Performance of Nanhua Bio's Accounting Firm for 2025

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Report on the Audit Committee's Oversight of the Accounting Firm's Performance in 2025

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Special Audit Report on Non-Operational Fund Occupation and Other Related Fund Transactions of Nanhua Biological

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

Summary of Non-Operating Fund Occupation and Other Related Fund Transactions for Nanhua Bio in 2025

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Special Opinion on the Independence Assessment of Independent Directors by the Board

Share Repurchase CompletionConvertible BondsShareholding Change Disclosure

2025 Annual Audit Report

Share PledgeShareholding Change DisclosureListed Company Announcements

2025 Annual Report

Share Repurchase CompletionShareholding Change DisclosureAnnual Report

Summary of the 2025 Annual Report

Share Repurchase CompletionShareholding Change DisclosureAnnual Report

Nanhua Biotech Announcement on Application to Withdraw Stock Delisting Risk Warning

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Seventh Risk Warning Announcement on Possible Delisting of Nanhua Bio Stocks

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Notes & Comments

Sign in to leave a comment or private note.

Loading…